Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis

類似資料

• Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
  著者:: Rivarola, C, 等
  出版事項: (2008)
• Methotrexate in oligoarticular persistent juvenile idiopathic arthritis
  著者:: Horneff, Gerd, 等
  出版事項: (2014)
• Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
  著者:: Bayraktar, S, 等
  出版事項: (2008)
• TNF‐alpha inhibitors for juvenile idiopathic arthritis
  著者:: Prince, Femke HM, 等
  出版事項: (2018)
• Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
  著者:: Roca, Clara Giménez, 等
  出版事項: (2014)